News
-
Monash pharmacist medal
Monday | Dec 12 2016ASSOCIATE Professor Michelle McIntosh from the Monash University Faculty of Pharmacy and Pharmaceutical Sciences has been jointly awarded the Dr John Dixon Hughes Medal for Medical Research Innovation by the National Foundation for Medical Research and Innovation.
-
GP career path preferred
Monday | Dec 12 2016THE most popular pharmacist career identified by the Pharmaceutical Society of Australia's new "Career Pathways" portal is as a General Practice Pharmacist, with almost 1,700 pharmacists across Australia having used the online tool since its launch at the PSA16 conference in Jul.
-
Events Calendar 09 Dec 16
Friday | Dec 9 2016If you have an upcoming event you'd like us to feature, email info@pharmacydaily.com.au.
-
Drug market tempers
Friday | Dec 9 2016TOTAL global spending on medicines is forecast to reach $1.5 trillion by 2021, up 33% from 2016 levels, even as annual growth moderates from the record pace set in 2014 and 2015, according to new research released from the QuintilesIMS Institute.
-
Choosing Wisely NZ
Friday | Dec 9 2016THE Choosing Wisely campaign championed by NPS MedicineWise has launched in New Zealand, mirroring the Austrailan approach by encouraging health professionals to talk to patients about unnecessary tests, treatments and procedures.
-
Platypus poison drug
Friday | Dec 9 2016RESEARCHERS from Monash University have taken part in a project which found evolutionary changes of insulin regulation in the platypus and the echidna could pave the way for new treatments for type 2 diabetes in humans.
-
Pharmacist insurance
Friday | Dec 9 2016NICHE business travel insurer, Professionals Travel Cover, has this week launched a travel cover product especially for pharmacists.
-
Pfizer fined re pricing
Friday | Dec 9 2016THE UK Competition and Markets Authority (CMA) slapped a "record" 84.2m fine on Pfizer, and a 5.2m fine on Flynn Pharma for their parts in charging "excessive and unfair" prices for epilepsy drug phenytoin sodium, with Pfizer planning to appeal, reports Chemist+Druggist.
-
MedAdvisor signs Pfizer
Friday | Dec 9 2016AUSTRALIAN-LISTED digital medication adherence company MedAdvisor has announced via the ASX that it has signed the Australian branch of the world's largest pharmaceutical company, Pfizer, to provide a Patient Engagement Program (PEP) for one of its leading medications.